home / stock / clabf / clabf news

CLABF News and Press, Core One Labs Inc. From 06/21/21

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: CLABF
Market: OTC
Website: lifestyledeliverysystem.com
Menu
CLABF CLABF Quote CLABF Short CLABF News CLABF Articles CLABF Message Board
Get CLABF Alerts

News, Short Squeeze, Breakout and More Instantly...
CLABF - REPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

VANCOUVER, British Columbia, June 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“ Akome ”) has co...
CLABF - Core One Labs' initiates development of AKO001 for neurological damage, files provisional patent

Core One Labs' (CLABF) wholly owned subsidiary Akome Biotech has commenced the development of a next-generation psychedelic drug formulation for the purpose of mitigating neurological damage that results from ischemic strokes. Akome’s psychedelic drug formulation, also known as AKO001,...

CLABF - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

VANCOUVER, British Columbia, June 19, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“ Akome ”) has co...

CLABF - Core One Labs Retains Canada's Highest-Ranked IP Law Firm to Assist With Patent Filings

VANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce it has retained Smart & Biggar LLP (“ Smart and Biggar ”) to handl...
CLABF - Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) advises that in preparation of a potential listing of its common shares on the Capital Market...

CLABF - REPEAT - Core One Labs' Biosynthesized Psilocybin Provisional Patent Imminent

VANCOUVER, British Columbia, June 14, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (“ Vocan ”...

CLABF - Core One Labs' Biosynthesized Psilocybin Provisional Patent Imminent

VANCOUVER, British Columbia, June 12, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (“ Vocan ”...
CLABF - Core One Labs Provides Clarification on Trading Activity

VANCOUVER, BC / ACCESSWIRE / May 21, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the " Company " or " Core One "). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada (" IIROC ") and the Canadian Secu...

CLABF - REPEAT - Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer's Disease

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (&#...

CLABF - Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer's Disease

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (&#...
Previous 10 Next 10